Chromosomal Abnormalities in Patients With Congenital Heart Disease at Assiut University Children's Hospital

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-18
SponsorAssiut University

About this trial

Congenital heart disease (CHD) is one of the most common birth defects and an important cause of infant morbidity and mortality. Many children with CHD also have underlying genetic abnormalities, particularly chromosomal abnormalities, which may affect their prognosis, management, and counseling. This study aims to determine the incidence and pattern of chromosomal abnormalities among children with CHD attending Assiut University Children's Hospital and Elmabara Insurance Hospital.

Children with a confirmed diagnosis of CHD will undergo a detailed clinical assessment, including dysmorphic evaluation, followed by chromosomal analysis (karyotyping). The study will help identify the frequency and type of chromosomal abnormalities associated with CHD and their correlation with specific cardiac defects and phenotypic features.

Understanding these genetic associations may improve diagnosis, early intervention, and family counseling, and provide useful information for risk stratification and prevention strategies in the Egyptian population.

Eligibility criteria

Qualifiers

Children with a confirmed diagnosis of congenital heart disease (by echocardiography and/or cardiology evaluation).

Age between 1 month and 18 years.

Patients attending Assiut University Children's Hospital or Elmabara Insurance Hospital during the study period.

Informed consent obtained from parents or legal guardians.

Disqualifiers

Patients with acquired (non-congenital) heart disease.

Critically ill patients in unstable condition not suitable for blood sampling.

Incomplete clinical data or refusal of parents/guardians to participate.

Trial design

Treatments tested in this trial

  • Conventional Karyotyping

Treatment groups

138 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators